Moonlake Immunotherapeutics

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$17.45

+0.74 (+4.43%)

As of Mar 25, 2:05 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 16 70%

Hold 4 17%

Sell 3 13%

Price Target

Analyst Price Target -39.6% upside

Low Target $8.06

Average Target $10.54

High Target $16.98

Current Price $17.45

Current
$17.45

Target
$10.54

$8.06 $10.54 avg $16.98

Scenario Analysis

Bear Case

$8.06

-53.8%

Low target

Base Case

$10.54

-39.6%

Avg target

Bull Case

$16.98

+-2.7%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$62.75

-72.2% from high

52-Week Low

$5.95

+193.3% from low

Target vs 52W High

$10.54

-83.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%